BetterLife Pharma (STU:NPAU) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:NPAU BetterLife Pharma Inc STU:NPAU
31 GF Score
Price €0.12
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma FFO?

FFO (Funds from operations) only applies to REITs.

STU:NPAU
31GF Score
BetterLife Pharma Inc STU:NPAU
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Business Description

Other Exchanges BETRF:USABETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
31GF Score

Get the complete analysis for STU:NPAU

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.12
Price